Your session is about to expire
← Back to Search
Advanced Imaging for Post-Traumatic Osteoarthritis
N/A
Recruiting
Led By J L Marsh, MD
Research Sponsored by J L Marsh
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Indicated for operative treatment
Sustained an intra-articular fracture of the tibial plafond
Must not have
Individuals younger than 18 and older than 70
Women who are pregnant or planning on becoming pregnant
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 18 months
Awards & highlights
No Placebo-Only Group
Summary
This trial will test a new CT system to see if it can detect joint degeneration and elevated contact stress more efficiently than other imaging modalities. The goal is to enable predictive models for osteoarthritis risk based on measures of post treatment contact stress.
Who is the study for?
This trial is for people aged 18-70 who need surgery after an ankle fracture involving the tibial plafond and can start treatment within 4 weeks of injury. Pregnant women or those planning pregnancy, and individuals outside this age range cannot participate.
What is being tested?
The study is evaluating a new standing CT scanner called pedCAT that may detect early joint degeneration and stress in weight-bearing poses better than current methods. It aims to improve osteoarthritis risk prediction post-injury.
What are the potential side effects?
Since the intervention involves imaging with a CT scanner, there are no direct side effects like with medications; however, there's exposure to low-dose radiation which carries minimal risk.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am recommended for surgery.
Select...
I have had a fracture inside my ankle joint.
Select...
I am between 18 and 70 years old.
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I am between 18 and 70 years old.
Select...
I am not pregnant and not planning to become pregnant.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 18 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~18 months
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Changes in the ankle joint space width
Secondary study objectives
Change in ankle function
Change in ankle pain
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: Experimental: pedCATExperimental Treatment1 Intervention
Subjects in this group will undergo weight-bearing CT (pedCAT) imaging at 6 months, 12 months, and 18 months post-ankle injury.
Find a Location
Who is running the clinical trial?
J L MarshLead Sponsor
1 Previous Clinical Trials
5 Total Patients Enrolled
1 Trials studying Osteoarthritis
5 Patients Enrolled for Osteoarthritis
Orthopaedic Trauma AssociationOTHER
33 Previous Clinical Trials
5,044 Total Patients Enrolled
J L Marsh, MD3.73 ReviewsPrincipal Investigator - University of Iowa
University of Iowa
5Patient Review
Dr. Marsh has been my go-to since 1993. They successfully mended my tibial plateau fracture with meniscus tear. I appreciated being kept in the loop regarding what they were doing and why. The results were perfect — minimal scarring. I had a second surgery 12 years later to remove the metal, and lastly in 2013 I had to have a knee replacement. I wouldn't go to anyone else.
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am seeking treatment within a month of my injury.I am between 18 and 70 years old.I am recommended for surgery.I have had a fracture inside my ankle joint.I am not pregnant and not planning to become pregnant.I am between 18 and 70 years old.
Research Study Groups:
This trial has the following groups:- Group 1: Experimental: pedCAT
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.